Artemisinin for Cancer Treatment

Medically Reviewed by Sabrina Felson, MD on June 09, 2022
2 min read

If you lived in China a thousand years ago and had a fever, inflammation, or malaria, a tea made from a flowering plant called Artemisia annua might have been your treatment. You may know it better as sweet wormwood.

The plant contains a compound called artemisinin. It's the basis for a malaria drug called artesunate that doctors prescribe today.

Some people believe that artemisinin may be an alternative to more aggressive cancer treatments. While cancer cells often become resistant to most chemotherapy drugs, that doesn’t seem to happen with artemisinin. And unlike many cancer treatments, artemisinin isn't toxic. It's also cheap and easy to give.

Cancer cells rely on iron to spread. When iron and artemisinin enter a cancer cell together, they form atoms called free radicals that kill cancer cells without harming normal ones.

Studies show that artemisinin may slow the spread of tumors. It could also cause cancer cells to:

  • Self-destruct
  • Stop dividing and spreading
  • Get cut off from their blood supply

There have been just a few small clinical trials that looked at artemisinin’s role in treating cancer. What research has been done used artemisinin in conjunction with normal cancer care, not as an alternative. We need more research to know for sure if it can help. So far, those small studies have some experts feeling optimistic about its potential role as a treatment for some types of cancer, including:

Colorectal. In a study of 20 people with colon cancer, nine were treated with artesunate while the rest were not. Those that received artesunate saw 12% more of their cancer cells die than those who didn't.

Melanoma. When taken in combination with a second drug, artesunate showed promise for people with melanoma of the eye that had spread. One person was still alive 47 months after they found out they had this form of skin cancer. By comparison, survival for this type of cancer is usually about 2-5 months.

Lung cancer. Researchers followed 120 cases of advanced non-small-cell lung cancer. People treated with a combination of artesunate and chemotherapy saw their cancer progress more slowly than those in a second group who didn't take these medicines together.

Advanced cervical cancer: Doctors treated 10 women with a form of artemisinin for 28 days. All 10 went into remission and saw symptoms like pain and vaginal discharge go away.

Possible side effects include:

Because there hasn't been much research on the use of artemisinin for treating cancer, there are lots of unknowns. If you're thinking about this as a potential treatment, you should talk with your medical team. They can tell you if there's a clinical trial available and if you could be a participant.

Show Sources


Memorial Sloan Kettering Cancer Center: “Artemisia annua.”

African Journal of Traditional, Complementary and Alternative Medicines: “Artemisia Annua as a Herbal Tea for Malaria.”

PubChem: “Artesunate (Compound).”

Trends in Pharmacological Sciences: “Artemisinins: their growing importance in medicine.”

Expert Opinion on Therapeutic Targets: “Targeted treatment of cancer with artemisinin and artemisinin-tagged iron-carrying compounds.”

Oncotarget: Open Access Impact Journal: “Artemisinin and its derivatives can significantly inhibit lung tumorigenesis and tumor metastasis through Wnt/β-catenin signaling.”

Pharmacology & Therapeutics: “Artemisinins: pharmacological actions beyond anti-malarial.”

International Journal of Oncology: “The anti-malarial artesunate is also active against cancer.”

Ecancermedicalscience: “The wisdom of crowds and the repurposing of artesunate as an anticancer drug.”

National Products and Bioprospecting: “Antitumor Research on Artemisinin and Its Bioactive Derivatives.”

Oncology Reports: “Artemisinin reduces cell proliferation and induces apoptosis in neuroblastoma.”

Anticancer Research: “Artemisinin induces apoptosis in human cancer cells.”

Phytomedicine: “Activity of Artemisia annua and artemisinin derivatives, in prostate carcinoma.”

Cancer Chemotherapy and Pharmacology: “The role of calcium, P38 MAPK in dihydroartemisinin-induced apoptosis of lung cancer PC-14 cells," “Investigation of ototoxicity of artesunate as add-on therapy in patients with metastatic or locally advanced breast cancer: new audiological results from a prospective, open, uncontrolled, monocentric phase I study.”

Ebiomedicine: “A Randomised, Double Blind, Placebo-Controlled Pilot Study of Oral Artesunate Therapy for Colorectal Cancer.”

Oncology Reports: “Artesunate in the treatment of metastatic uveal melanoma--first experiences.”

Journal of Chinese Integrative Medicine: “[Artesunate combined with vinorelbine plus cisplatin in treatment of advanced non-small cell lung cancer: a randomized controlled trial].”

Anticancer Research: “First study of oral Artenimol-R in advanced cervical cancer: clinical benefit, tolerability and tumor markers.”

Journal of Ethnopharmacology: “The complexity of medicinal plants: the traditional Artemisia annua formulation, current status and future perspectives.”

View privacy policy, copyright and trust info